Fifth International Hospital Diabetes Meeting
May 8-9, 2015 at the Hyatt Regency San Francisco Airport
1333 Bayshore Highway, Burlingame, CA 94010
Regency Ballroom
Friday May 8, 2015
08:00
Welcome
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Health Services, San Mateo, California
Keynote Address
08:05
Hospital Safety for Diabetes: The Joint Commission Perspective
Erin S. DuPree, MD, FACOG
Joint Commission Center for Transforming Healthcare, Oakbrook Terrace,
Illinois
Session 1: Measuring Glucose in Hospitalized and Critically Ill Patients
08:35
Glucometrics – What to Report
Greg Maynard, MD, MSc, SFHM
UC Davis, Sacramento, California
08:55
Glucose Variability in the Hospital Setting: Causes and Solutions
Gerry Rayman, MD, FRCP
Ipswich Hospital Diabetes Center, Ipswich, UK
09:15
POC Blood Glucose Monitoring and Impact of FDA Guidelines for
Critically Ill Patients
Mitchell G. Scott, PhD, DABCC
Washington University, Saint Louis, Missouri
09:45
Impact of CMS Guidelines on POC BGM in Critically Ill Patients
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Health Services, San Mateo, California
09:55
Group Discussion
10:15
Break
Session 2: Glycemic Targets in Various Settings
10:40
ICU
Stanley A. Nasraway, MD
Tufts Medical Center, Boston Massachusetts
11:00
Non-ICU
Garry S. Tobin, MD
Washington University, Saint Louis, Missouri
11:20
Pediatric ICU
Darrell M. Wilson, MD
Stanford University, Stanford, California
11:40
Transitions in Diabetes Care: Inpatient to Outpatient
Amisha Wallia, MD, MS
Northwestern Medical Group, Chicago, Illinois
12:00
Group Discussion
12:20
Lunch
12:40
Lunch Program – Avoiding Bloodborne Diseases
Avoiding Bloodborne Virus Disease Transmission from Assisted
Monitoring of Blood Glucose in the Hospital; a Pathologist‘s
Perspective
Sharon Geaghan, MD
Stanford University, Stanford, California
Christel Marchand Aprigliano
StripSafely, Tampa, Florida
13:20
Break
Session 3: Technology
13:50
BGM in the Hospital – State of the Art
Mitchell G. Scott, PhD, DABCC
Washington University, Saint Louis, Missouri
14:10
Continuous Glucose Monitoring in the Hospital
Stanley A. Nasraway, MD
Tufts Medical Center, Boston Massachusetts
14:30
Computerized Insulin Infusion Programs (Glucommander and Others)
Guillermo Umpierrez, MD
Emory University, Atlanta, Georgia
14:50
Regulation of Glucose Monitoring and Insulin Dosing Software for
Hospitalized Patients
Alberto Gutierrez, PhD
U.S. Food and Drug Administration, Silver Spring, Maryland
15:10
Group Discussion
15:30
Break
Session 4: Glucose Management Teams
15:55
The Role of Certified Diabetes Educators (CDEs)
Jane Jeffrie Seley, DNP, MPH, GNP, BC-ADM, CDE, CDTC
New York-Presbyterian/Weill Cornell, New York, New York
16:15
Collaborative Model to Enhance Surgical Diabetes Patient Care
Curtiss B. Cook, MD
Mayo Clinic, Scottsdale, Arizona
16:35
The Virtual Inpatient Glucose Management Service
Robert J. Rushakoff, MD
UC San Francisco, San Francisco, California
16:55
Group Discussion
17:10
Adjourn
Saturday May 9, 2015
08:00
Introduction
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Health Services, San Mateo, California
Session 5: Insulin Dosing and Safety
08:05
Algorithms
Greg Maynard, MD, MSc, SFHM
UC Davis, Sacramento, California
08:25
Decision Support Software
Thomas Pieber, MD
Medical University of Graz, Graz, Austria
08:45
Creating User-Friendly Insulin Order Sets: Balancing Safety and
Efficacy
Jane Jeffrie Seley, DNP, MPH, GNP, BC-ADM, CDE, CDTC
New York-Presbyterian/Weill Cornell, New York, New York
09:05
Pump Safety in the Hospital in Various Settings Including OR and
Radiology
Robert J. Rushakoff, MD
UC San Francisco, San Francisco, California
09:25
Group Discussion
09:50
Break
Session 6: Hypoglycemia
10:15
Mechanisms/Symptoms/Frequency
Thomas Pieber, MD
Medical University of Graz, Graz, Austria
10:35
Prevention
Garry S. Tobin, MD
Washington University, Saint Louis, Missouri
10:55
Outcomes
Mikhail Kosiborod, MD
Saint Luke’s Mid America Heart Institute, Kansas City, Missouri
11:15
The Economic Burden of Hypoglycemia
Robert A. Vigersky, MD
Medical Director, Medical Affairs, Medtronic Diabetes
Professor of Medicine
Uniformed Services University of the Health Sciences
Director Emeritus
Diabetes Institute
Walter Reed National Military Medical Center
11:35
Group Discussion
12:00
Lunch
Session 7: Special Populations
13:00
Steroids, Tube Feeding, and TPN
Boris Draznin, MD, PhD
University of Colorado, Aurora, Colorado
13:20
Special Situations: Surgery
Mark J. Rice, MD
Vanderbilt University, Nashville, Tennessee
13:40
Transplant Management
Amisha Wallia, MD, MS
Northwestern Medical Group, Chicago, Illinois
14:00
Foot Disease in the Hospital
Gerry Rayman, MD, FRCP
Ipswich Hospital Diabetes Center, Ipswich, UK
14:20
Group Discussion
14:45
Break
Session 8: Novel Therapeutics
15:10
New Insulins
Robert A. Vigersky, MD
Medical Director, Medical Affairs, Medtronic Diabetes
Professor of Medicine
Uniformed Services University of the Health Sciences
Director Emeritus
Diabetes Institute
Walter Reed National Military Medical Center
15:35
Insulin Pump Therapy In The Perioperative Period: Update on a
Quality Initiative
Curtiss B. Cook, MD
Mayo Clinic, Scottsdale, Arizona
16:00
SGLT2 Inhibitors
Mikhail Kosiborod, MD
Saint Luke’s Mid America Heart Institute, Kansas City, Missouri
16:25
Group Discussion
16:50
Closing Remarks
Robert A. Vigersky, MD
Medical Director, Medical Affairs, Medtronic Diabetes
Professor of Medicine
Uniformed Services University of the Health Sciences
Director Emeritus
Diabetes Institute
Walter Reed National Military Medical Center
17:00
Adjourn